Skip to main content
Premium Trial:

Request an Annual Quote

UK Health Secretary Steps Down

The UK health secretary, Matt Hancock, has resigned after violating COVID-19 restrictions, the Associated Press reports.

The UK tabloid the Sun published pictures of Hancock kissing an aide that it said was taken in early May before COVID-19 restrictions preventing physical contact between individuals from different households were eased, the AP says, noting that both Hancock and the aide are married to others. This prompted calls for Hancock, who, as health minister, implemented the restrictions, to step down, it adds.

"People have made huge sacrifices to beat the pandemic," Andrew Bridgen, an MP, tells BBC News. "And what riles them is the whiff of hypocrisy that people make the rules and don't stick to them themselves."

Hancock resigned Saturday. He previously apologized for the breaching the restrictions, Reuters reports.

The AP notes that other officials in the UK have been caught in violation of social distancing rules including Dominic Cummings and Neil Ferguson, and that when Ferguson's violation came to light, Hancock said the restrictions "are there for everyone."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.